Navigation Links
Alliance for Lupus NYC Walk With Us to Cure Lupus First Lupus Walk In History To Raise $1-Million
Date:10/27/2011

NEW YORK, Oct. 27, 2011 /PRNewswire-USNewswire/ -- A milestone in lupus research was met this weekend!  On Saturday, October 22nd the Alliance for Lupus Research (ALR) held its 8th annual New York City Walk with Us to Cure Lupus.  The beautiful weather at Battery Park was matched by the enthusiasm of the nearly 3000 walkers in attendance to walk for the cure.  The walkers were joined by NYC master of ceremonies, My9 news anchor Brenda Blackmon, ALR Chairman Robert Wood Johnson IV, and Walk Co-chairs Frank Bisignano, Chief Administrative Officer JPMorgan Chase; Daniel LaVecchia, Executive Managing Director BGC Partners; and Mark Wagar, President & CEO Empire BlueCross BlueShield.  Spoken poet Shanelle Gabriel inspired the crowd with "Vanity", her moving personal account of life with lupus. 

The ALR NYC Walk with Us to Cure Lupus is the first lupus Walk in history to raise $1 million!  That's $1 million to fund research supporting the ALR's mission of finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE, or lupus).   Not only did the ALR surpass the Walk's initial goal of $900,000; we made history.  The Walk provided a wonderful opportunity to give a voice to people affected by lupus.  We thank everyone for their support and unwavering commitment.

The Walk was supported by corporate sponsors Johnson & Johnson, Cantor Fitzgerald, BGC Partners, JPMorgan Chase, Empire BlueCross BlueShield, New York Yankees, New York Mets, Trump Organization, KPF Associates, Bank of America/Merrill Lynch, Human Genome Sciences, Pfizer, Montefiore The University Hospital for Albert Einstein College of Medicine, Bank of New York Mellon, KPMG, Verizon, Kraft Foods, CBS Sports, and Turner Construction Company.

About Lupus
Systemic lupus erythematosus (SLE, or lupus) is a chronic autoimmune disease that can affect the joints and almost every major organ in the body, including the heart, kidneys, skin, lungs, and brain.  As many as 1.5 million people in the United States have lupus which affects mostly women during childbearing years, though men and children can have the disease.  Lupus is three times more common in African-American women than in Caucasian women and is also more prevalent in women of Latino, Asian, and Native American descent.

About the ALR
The Alliance for Lupus Research (ALR) is a national voluntary health organization dedicated to finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE, or lupus), a debilitating autoimmune disease.  The organization is based in New York City and chaired by Robert Wood Johnson IV, a member of the founding family of Johnson & Johnson.  Since its founding in 1999, the ALR has given more money to lupus research than any non-governmental agency in the world.  The board of directors funds all administrative and fundraising costs, allowing one hundred percent of all donations from the public, and the proceeds of our signature grassroots fundraising program, Walk with Us to Cure Lupus, go directly to support research programs.  The organization has awarded more than $6 million in grants this year and, since 1999, has dedicated over $67 million to understanding the disease. More information can be found at www.lupusresearch.org.


'/>"/>
SOURCE Alliance for Lupus Research
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
2. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
3. Lung Cancer Alliance Commends NCCN on Screening Guidelines
4. Lung Cancer Alliance Hails Announcement of New Erbitux(R) Data
5. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
6. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
7. Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
8. ICON and MedAvante Sign Alliance Agreement
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
11. SIRO Clinpharm and CambReg Ltd Strategic Alliance to Offer Regulatory Services in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Corp., also known as ,The Epigenetics Company, announced today the release of ... using the myDNAge ™ test. Based on Horvath,s Clock, so named ... biostatistics at the David Geffen School of Medicine at UCLA ... ™ technology is used to analyze DNA methylation patterns of over ... Epigenetic ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... TRIANGLE PARK, N.C. , July 10, 2017 /PRNewswire/ ... a $5m Convertible Note to support the development of ... by Tencent Holdings Limited, a leading Chinese Internet services ... This funding will advance multiple infectious disease product programs ... Founded by Dr. ...
Breaking Medicine Technology:
(Date:7/20/2017)... (PRWEB) , ... July 19, 2017 , ... ... a $1.5 million Health Resources and Services Administration (HRSA) grant to train predoctoral ... special health care needs in rural and underserved areas. , The Predoctoral Pediatric ...
(Date:7/20/2017)... ... 19, 2017 , ... A July 7th article ... varicose veins in some patients, according to medical experts. Washington State medical clinic ... excessive sitting or standing, or regularly nicking yourself while shaving your legs, and ...
(Date:7/18/2017)... ... 18, 2017 , ... CannaKids, a California Cooperative Cooperation that specializes in the ... the WORLDZ Summit, taking place in Hollywood from July 31-August 1, the Company’s ... cannabis for both pediatric and adult patients, and how the path has led her ...
(Date:7/18/2017)... ... July 18, 2017 , ... The results of an international clinical trial, led in part by ... severe type of muscular dystrophy holds promise for a subgroup of patients. , In a ... and colleagues at 53 study sites in 18 countries describe the clinical benefit of using ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Seattle, Wash., has developed ... to clean, scrub and moisturize the back and other hard-to-reach areas of the body. ... movement in my upper body, particularly my shoulders. I found it difficult to reach ...
Breaking Medicine News(10 mins):